These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis. Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644 [TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism. Kelley D; Wright L; Ohman K; Ferreira J J Thromb Thrombolysis; 2018 Jul; 46(1):58-61. PubMed ID: 29797208 [TBL] [Abstract][Full Text] [Related]
27. Use of direct oral anticoagulants in patients on immunomodulatory agents. Man L; Morris A; Brown J; Palkimas S; Davidson K J Thromb Thrombolysis; 2017 Oct; 44(3):298-302. PubMed ID: 28819709 [TBL] [Abstract][Full Text] [Related]
28. Pharmacology of anticoagulants used in the treatment of venous thromboembolism. Nutescu EA; Burnett A; Fanikos J; Spinler S; Wittkowsky A J Thromb Thrombolysis; 2016 Jan; 41(1):15-31. PubMed ID: 26780737 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study. Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958 [TBL] [Abstract][Full Text] [Related]
30. Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration. Din N; Fan J; Schmitt S; Guo JD; Hlavacek P; Pundi K; Russ C; Emir B; Turakhia MP; Perino AC Clin Appl Thromb Hemost; 2023; 29():10760296231152474. PubMed ID: 36694957 [TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Fang MC; Go AS; Prasad PA; Zhou HX; Parks AL; Fan D; Portugal C; Sung SH; Reynolds K Thromb Res; 2022 Aug; 216():97-102. PubMed ID: 35779378 [TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726 [TBL] [Abstract][Full Text] [Related]
33. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis. Wu S; Lv M; Chen J; Jiang S; Chen M; Fang Z; Zeng Z; Qian J; Xu W; Guan C; Zhang J Support Care Cancer; 2022 Dec; 30(12):10407-10420. PubMed ID: 36318341 [TBL] [Abstract][Full Text] [Related]
34. Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan. Nakamura M; Yamada N; Ito M J Atheroscler Thromb; 2017 Jun; 24(6):560-565. PubMed ID: 28392512 [TBL] [Abstract][Full Text] [Related]
35. Comparative Safety and Effectiveness of Direct Oral Anticoagulants and Warfarin during Chemotherapy in Cancer Patients with Venous Thromboembolism Aged 75 Years or Older: A Nationwide Inpatient Database Study. Iwai C; Jo T; Konishi T; Kumazawa R; Matsui H; Fushimi K; Yasunaga H Gerontology; 2023; 69(5):561-570. PubMed ID: 36502790 [TBL] [Abstract][Full Text] [Related]
36. Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study. Khan AM; Chiasakul T; Redd R; Patell R; McCarthy EP; Neuberg D; Zwicker JI PLoS Med; 2022 May; 19(5):e1004012. PubMed ID: 35613184 [TBL] [Abstract][Full Text] [Related]
37. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis. Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830 [TBL] [Abstract][Full Text] [Related]
38. The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead? Cohen AT; Granziera S; Veronese N; Zoppellaro G Semin Respir Crit Care Med; 2017 Feb; 38(1):29-39. PubMed ID: 28208196 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min. Cline L; Generoso EMG; D'Apice N; Dellinger SK; Tovey A; Clark NP; Nui F; Hui R; Hale SA; Ramsey T; Pontoppidan K; Ekmekdjian H; Fink K; Witt DM; Crowther MA; Delate T J Thromb Thrombolysis; 2023 Feb; 55(2):355-364. PubMed ID: 36564588 [TBL] [Abstract][Full Text] [Related]
40. Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge. Basto AN; Fewel NP; Vo K; Stock EM; Ta M J Thromb Thrombolysis; 2018 Jan; 45(1):51-55. PubMed ID: 29086244 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]